title: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds? Author's response.
authors.forename: G J
authors.initials: GJ
authors.lastname: Kontoghiorghes
mesh_terms: D001565:Benzoates / Q000009:adverse effects*; D000077588:Deferasirox; D006801:Humans; D007502:Iron Chelating Agents / Q000009:adverse effects*; D061214:Patient Safety; D014230:Triazoles / Q000009:adverse effects*
chemical_list: D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox